Pac Soo, Vanessa https://orcid.org/0000-0002-6276-6920
Baker, Felicity A.
Sousa, Tanara Vieira
Odell-Miller, Helen
Stensæth, Karette
Wosch, Thomas
Bukowska, Anna A.
Tamplin, Jeanette
Lautenschlager, Nicola
Braat, Sabine
Lamb, Karen E.
Funding for this research was provided by:
Joint Programs for Neurodegenerative Diseases and the National Health and Medical Research Council (GNT1169867)
Norwegian Research Council (298995)
Federal Ministry of Education and Research Germany (01ED1901)
The National Centre for Research and Development, Poland (JPND/04/2019)
The National Centre for Research and Development at Alzheimer’s Society, UK (462)
Article History
Received: 17 January 2023
Accepted: 24 April 2023
First Online: 8 May 2023
Declarations
:
: Each country obtained ethics approval prior to the commencement of the trial (Australia [Human Ethics Sub-Committee approval no. 1852845]; Germany [approval no. DGP 19-013]; Norway [Norwegian Centre for Research Data (Ref 502736) and Norwegian REK Medical and Research Ethics Ref 2019/941]; Poland [approval no. 186/KBL/OIL/2019]; UK Integrated Research Application System (IRAS) [approval no. 19/EE/0177]). Results will be disseminated in international peer-reviewed journal(s) and at scientific meetings. Informed consent was provided from all dyads.
: Not applicable.
: The authors declare that they have no competing interests.